CP

Caligan Partners Portfolio holdings

AUM $1.41B
1-Year Est. Return 518.95%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+518.95%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.41B
AUM Growth
+$321M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
30
New
Increased
Reduced
Closed

Top Buys

1 +$38.9M
2 +$37.3M
3 +$33.2M
4
SYRE icon
Spyre Therapeutics
SYRE
+$33.1M
5
SABS icon
SAB Biotherapeutics
SABS
+$31.8M

Top Sells

1 +$25.6M
2 +$21.8M
3 +$18.4M
4
SPRB
Spruce Biosciences
SPRB
+$1.79M
5
ELDN icon
Eledon Pharmaceuticals
ELDN
+$840K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LQDA icon
1
Liquidia Corp
LQDA
$4.78B
$306M 21.67%
8,118,892
ABVX
2
Abivax
ABVX
$6.63B
$163M 11.51%
1,461,924
+10,000
RVMD icon
3
Revolution Medicines
RVMD
$32.8B
$161M 11.37%
1,652,808
+368,908
PCVX icon
4
Vaxcyte
PCVX
$6.81B
$120M 8.47%
2,060,719
+355,904
XENE icon
5
Xenon Pharmaceuticals
XENE
$5.18B
$81M 5.73%
1,393,027
+843,362
MLYS icon
6
Mineralys Therapeutics
MLYS
$2.04B
$75.1M 5.31%
2,772,654
EXEL icon
7
Exelixis
EXEL
$12.7B
$66.6M 4.71%
1,553,262
TNGX icon
8
Tango Therapeutics
TNGX
$3.1B
$50.4M 3.56%
2,408,798
-1,321,097
TYRA icon
9
Tyra Biosciences
TYRA
$1.75B
$48.9M 3.46%
1,276,968
+332,711
SYRE icon
10
Spyre Therapeutics
SYRE
$6.46B
$44.3M 3.13%
+878,127
ADMA icon
11
ADMA Biologics
ADMA
$1.77B
$42.9M 3.03%
4,756,511
+1,744,003
LBRX
12
LB Pharmaceuticals
LBRX
$808M
$34.6M 2.45%
+1,438,070
VOR icon
13
Vor Biopharma
VOR
$728M
$34.3M 2.43%
1,925,066
+999,999
SABS icon
14
SAB Biotherapeutics
SABS
$258M
$30.5M 2.16%
+7,967,207
IRD
15
Opus Genetics
IRD
$326M
$27.6M 1.96%
+6,075,028
IVA
16
Inventiva
IVA
$844M
$27.6M 1.95%
4,974,906
+2,974,906
MBX
17
MBX Biosciences
MBX
$1.44B
$25.3M 1.79%
+848,590
AVTX icon
18
Avalo Therapeutics
AVTX
$739M
$24.4M 1.73%
1,635,023
+753,490
ANIK icon
19
Anika Therapeutics
ANIK
$189M
$20.8M 1.47%
1,435,130
MAZE
20
Maze Therapeutics
MAZE
$1.36B
$18.4M 1.3%
614,962
+64,771
VRCA icon
21
Verrica Pharmaceuticals
VRCA
$98.9M
$4.89M 0.35%
923,910
SNSE icon
22
Sensei Biotherapeutics
SNSE
$24.2M
$3.97M 0.28%
+126,002
AURA icon
23
Aura Biosciences
AURA
$708M
$1.54M 0.11%
+229,864
XLO icon
24
Xilio Therapeutics
XLO
$53.9M
$943K 0.07%
+112,128
AGIO icon
25
Agios Pharmaceuticals
AGIO
$1.63B
0